Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology

Written By Lisa Bloudek
 
 
 
 
 

Curta researchers are proud to introduce the Oncology Simulation Model (OSM), a novel model framework that combines and extends existing modeling practices into an innovative and dynamic simulation model to estimate prevalence and survival in oncology. This flexible framework can be leveraged to answer many research questions considering efficacy, treatment patterns, and sequencing.

The full text can be accessed in November's Clinical Epidemiology https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673939/.

 
Lisa Bloudek
Previous

HER2 Expression in Urothelial Carcinoma, A Systematic Literature Review
Next

Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies